| Effects of alpha(1)-adrenoceptor antagonists on male sexual function. | |
| | |
MedLine Citation:
|
PMID: 16526818 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
alpha(1)-Adrenoceptor antagonists such as alfuzosin, doxazosin, tamsulosin and terazosin are first-line agents for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH), but are only second-line agents (doxazosin and terazosin only) for the treatment of arterial hypertension. Sexual function is complex and includes multiple domains such as sexual desire (libido), erectile function and ejaculatory function. Erectile and ejaculatory functions are frequently reduced in patients with BPH and can impact on their quality of life. Therefore, the treatment of BPH should aim to maintain or even restore sexual function.alpha(1)-Adrenoceptor antagonists lack major effects on sexual desire in placebo-controlled studies. Reports on erectile function are inconsistent, with both beneficial and adverse effects being reported, but impotence can occur in some patients without clear differences between drugs. Ejaculatory dysfunction during treatment may represent (relative) an ejaculation. It occurs more frequently with tamsulosin than with other drugs of this class, but the differences are not big enough to be consistently detectable in directly comparative studies. We propose that such differences between drugs should be weighed against differences in cardiovascular tolerability when choosing the optimal treatment for each patient. |
| | |
Authors:
|
Marleen M van Dijk; Jean J M C H de la Rosette; Martin C Michel |
Related Documents
:
|
22854528 - Innovative technologies for sfa occlusions: drug coated balloons in sfa lesions. 19178128 - Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pent... 22510218 - Comparative drug dose and drug combinations in patients that present to hospital due to... 22873498 - Exploratory and regulatory assessments on photosafety of new drug entities. 17498898 - Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble dr... 17943448 - Neuropsychological and behavioral effects of antiepilepsy drugs. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Drugs Volume: 66 ISSN: 0012-6667 ISO Abbreviation: Drugs Publication Date: 2006 |
Date Detail:
|
Created Date: 2006-03-10 Completed Date: 2006-07-21 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7600076 Medline TA: Drugs Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 287-301 Citation Subset: IM |
Affiliation:
|
Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic Antagonists
/
adverse effects,
pharmacology* Adult Aged Doxazosin / adverse effects, pharmacology Ejaculation / drug effects* Erectile Dysfunction / etiology Humans Libido / drug effects* Male Middle Aged Penile Erection / drug effects* Prostatic Hyperplasia / drug therapy, metabolism Quinazolines / adverse effects, pharmacology Randomized Controlled Trials as Topic Receptors, Adrenergic, alpha-1 / antagonists & inhibitors*, metabolism Sulfonamides / adverse effects, pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic Antagonists; 0/Quinazolines; 0/Receptors, Adrenergic, alpha-1; 0/Sulfonamides; 106133-20-4/tamsulosin; 74191-85-8/Doxazosin; 81403-80-7/alfuzosin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?
Next Document: Travellers' diarrhoea: contemporary approaches to therapy and prevention.